Prevalence of Metabolic Syndrome and its Clinical and Angiographic Profile in Patients with Naive Acute Coronary Syndrome

Mahmood Dhahir Al-Mendalawi
{"title":"Prevalence of Metabolic Syndrome and its Clinical and Angiographic Profile in Patients with Naive Acute Coronary Syndrome","authors":"Mahmood Dhahir Al-Mendalawi","doi":"10.4103/jicc.jicc_41_22","DOIUrl":null,"url":null,"abstract":"Sir, Kumar et al.[1] found in their study that the metabolic syndrome (MetS) prevalence was high (46.2%) among Indian patients with naive acute coronary syndrome (ACS) and patients with MetS tended to have more complex coronary lesions. Based on the following limitation, we believe that the study findings are questionable. The revised National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATP III) guidelines[2] employed in the study to diagnose MetS include the following parameters: (1) abdominal obesity manifests as waist circumference (WC) ≥102 cm for men or ≥88 cm for women; (2) serum triglyceride (TG) level ≥150 mg/dL; (3) serum high-density lipoprotein cholesterol (HDLC) level ≤40 mg/dL for men or ≤50 mg/dL for women; (4) systolic/diastolic blood pressure (BP) ≥130/85 mmHg or receiving drug therapy; and (5) fasting plasma glucose (FBG) ≥100 mg/d. These guidelines were launched in 2005[2] and they are no more righteous. Around the world, many committees have built their MetS definition guidelines centered on various factors such as age, gender, pubertal stage, socioeconomic class, and ethnicity to accurately measure MetS prevalence.[3,4] Importantly, India released national diagnostic guidelines for MetS in 2016. These guidelines involve the following components: (1) WC ≥31” In women and ≥35” in men; (2) serum TG level ≥150 mg/dl; (3) serum HDLC level <50 mg/dl for women and <40 mg/dl for men; (4) BP ≥130/85 mmHg; and (5) FBG >100 mg/dl.[5] Since there are noticeable variations between the revised NCEP/ATP III guidelines[2] and national MetS diagnostic guidelines,[5] we believe that referring to the national guidelines could make an accurate estimate of the MetS prevalence among ACS Indian patients and assess the seriousness of coronary artery disease in those with and without MetS. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.","PeriodicalId":100789,"journal":{"name":"Journal of Indian College of Cardiology","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Indian College of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jicc.jicc_41_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Sir, Kumar et al.[1] found in their study that the metabolic syndrome (MetS) prevalence was high (46.2%) among Indian patients with naive acute coronary syndrome (ACS) and patients with MetS tended to have more complex coronary lesions. Based on the following limitation, we believe that the study findings are questionable. The revised National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATP III) guidelines[2] employed in the study to diagnose MetS include the following parameters: (1) abdominal obesity manifests as waist circumference (WC) ≥102 cm for men or ≥88 cm for women; (2) serum triglyceride (TG) level ≥150 mg/dL; (3) serum high-density lipoprotein cholesterol (HDLC) level ≤40 mg/dL for men or ≤50 mg/dL for women; (4) systolic/diastolic blood pressure (BP) ≥130/85 mmHg or receiving drug therapy; and (5) fasting plasma glucose (FBG) ≥100 mg/d. These guidelines were launched in 2005[2] and they are no more righteous. Around the world, many committees have built their MetS definition guidelines centered on various factors such as age, gender, pubertal stage, socioeconomic class, and ethnicity to accurately measure MetS prevalence.[3,4] Importantly, India released national diagnostic guidelines for MetS in 2016. These guidelines involve the following components: (1) WC ≥31” In women and ≥35” in men; (2) serum TG level ≥150 mg/dl; (3) serum HDLC level <50 mg/dl for women and <40 mg/dl for men; (4) BP ≥130/85 mmHg; and (5) FBG >100 mg/dl.[5] Since there are noticeable variations between the revised NCEP/ATP III guidelines[2] and national MetS diagnostic guidelines,[5] we believe that referring to the national guidelines could make an accurate estimate of the MetS prevalence among ACS Indian patients and assess the seriousness of coronary artery disease in those with and without MetS. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
原发性急性冠脉综合征患者代谢综合征的患病率及其临床和血管造影特征
Sir、Kumar等[1]研究发现,印度初发急性冠脉综合征(ACS)患者中代谢综合征(MetS)患病率较高(46.2%),且met患者往往有更复杂的冠状动脉病变。基于以下限制,我们认为研究结果值得怀疑。本研究采用修订后的国家胆固醇教育计划/成人治疗小组III (NCEP/ATP III)指南[2]诊断MetS包括以下参数:(1)腹部肥胖表现为男性腰围(WC)≥102 cm或女性≥88 cm;(2)血清甘油三酯(TG)水平≥150mg /dL;(3)血清高密度脂蛋白胆固醇(HDLC)水平男性≤40 mg/dL,女性≤50 mg/dL;(4)收缩压/舒张压(BP)≥130/85 mmHg或正在接受药物治疗;(5)空腹血糖(FBG)≥100mg /d。这些指导方针于2005年推出[2],它们不再是正义的。在世界范围内,许多委员会已经建立了他们的MetS定义指南,以各种因素为中心,如年龄,性别,青春期阶段,社会经济阶层和种族,以准确衡量MetS的患病率。[3,4]重要的是,印度于2016年发布了met的国家诊断指南。这些指南包括以下内容:(1)女性WC≥31,男性WC≥35;(2)血清TG水平≥150mg /dl;(3)血清HDLC水平100 mg/dl。[5]由于修订后的NCEP/ATP III指南[2]与国家MetS诊断指南之间存在明显差异,[5]我们认为,参考国家指南可以准确估计ACS印度患者的MetS患病率,并评估有无MetS患者冠状动脉疾病的严重程度。财政支持及赞助无。利益冲突没有利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信